About
BridgeBio aims to foster innovation, awareness and collaboration in the synthetic biology business ecosystem, as well as create a supportive and inclusive community to bridge the gap between industry, academia and stakeholders.
BridgeBio will explore the importance and strategies for stakeholder engagement with iGEMers, industrialists and biofounders through a series of workshops and roundtable discussions in order to increase the exposure of iGEM and synthetic biology among regional stakeholders who promote communication and cooperation across their community.
Goals
Bridge the gap between iGEMers and the real world, where technologies created by them are made available to industries and users of these innovative systems.
Empower and support women and underrepresented groups interested in pursuing careers or starting businesses in the field of synthetic biology by providing them with resources, mentorship, and networking opportunities.
Build an open and inclusive SynBio business community where people can share knowledge and build connections while empowering and motivating each other.
Bring more exposure to iGEM and synthetic biology from this initiative of collaboration with local stakeholders who disseminate cooperation across their community.
Provide iGEMers and biofounders with strategies for improved communication and advertising with broad audiences outside iGEM, Academia and Research.
Workshops
We build workshops focusing on four main topics
Breaking down industry buzzwords and jargon, such as intellectual property, commercialisation and marketing strategies to provide a comprehensive understanding of the business side of synthetic biology. This will provide attendees with practical skills and conceptual knowledge that can be applied to their own research or business ventures/industry.
Career Orientation Camps for high Schoolers to inform them about iGEM, the iGEM community and its working. These workshops will aim to inform students about the syn-bio cohort, helping them understand its importance and how they can be a part of this community.
Maintaining balance between your science and the stakeholder. This workshop will provide understanding of the various types of Stakeholder Engagement, the importance of Stakeholder engagement (The pitfalls of not getting outside views) and ways in identifying relevant stakeholders.
Assessing the impact and feasibility of potential products through stakeholder engagement ways in creating feedback loops between a synthetic biology project and the world in which it exists involves Reflection, Responsibility and Responsiveness.
Talks
We will feature talks by business leaders, industrialists and ex-iGEMers who will share their journey in the industry and discuss career opportunities and challenges in the field.
Conversation with Dr. Tae Seok Moon
The conversation with Dr. Tae Seok Moon, Professor, SynBYSS Chair & EBRC Council Member, delved into the world of programmable organisms with a talk on “Systems and synthetic biology: constructing smart and programmable microbes to address global problems”.
Leading Ladies of SynBio
The Leading Ladies of Synbio attempts to invite women leaders in the synthetic biology industry to share the current state of the industry, insights into launching products and projects, and advice for you!
Interview with Dr. Claire Aldridge, CSO, Form Bio
Join Dr. Claire Aldridge, Ph.D. and Chief Strategy Officer for Form Bio, for the second session of the "Leading Ladies of SynBio" series. Form Bio is the first spinout from the de-extinction and biodiversity company, Colossal Biosciences. Dr. Aldridge brings more than 25 years’ experience facilitating the translation of scientific discoveries into patient and commercial benefits and has leveraged her training to be a liaison between scientists and non-scientists.
Interview with Dr. Aoife Brennan, CEO, Synlogic Inc.
Join Dr. Aoife Brennan, President and CEO of Synlogic, for our first session of the "Leading Ladies of SynBio" series. Dr. Brennan is an experienced physician scientist and drug developer responsible for the successful clinical development and registration of multiple transformative medicines. She has served as Synlogic’s president and chief executive officer since May 2018. She joined Synlogic in September 2016 as chief medical officer. Prior to Synlogic, Aoife spent six years at Biogen, most recently as vice president and head of the Rare Disease Innovation Unit, developing programs from pre-clinical to commercial.
Blogs
We will create blogs to reach a wider audience, through articles with detailed experiences of stakeholder interactions, learnings from workshops and talks as planned under the project. These will also highlight new opportunities/jobs available in different sectors.
BridgeBio: Connecting the Synthetic Biology Industry and Community
Treating Metabolic Disorders with Synthetic Biology: Interview with Dr. Aoife Brennan
Recruitment is currently closed! You can connect with us on Slack for more information!